STEMI - ST Elevation Myocardial Infarction Clinical Trial
Official title:
A Randomized, Controlled, Pilot Study to Evaluate Safety and Feasibility of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy in Patients With ST Elevation Inferior Wall Myocardial Infarction Presenting With TIMI 0 or 1 and Symptom Duration ≤ 12 Hours Treated Adjunct to Percutaneous Coronary Intervention (PCI) Compared to Standard PCI.
The objective of this study is to assess safety and feasibility of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) therapy in patients with extensive ST elevation inferior wall myocardial infarction presenting with TIMI 0 or 1 and symptom duration ≤ 12 hours undergoing percutaneous coronary intervention (PCI) compared to standard PCI.
This is a multicenter, randomized (2 PiCSO :1 Control), controlled, pilot study to evaluate safety and feasibility of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) therapy in patients with extensive ST elevation inferior wall myocardial infarction presenting with TIMI 0 or 1 and symptom duration ≤ 12 hours treated adjunct to percutaneous coronary intervention (PCI) compared to standard PCI. Patients with an ST-segment elevated inferior infarct eligible for PCI will be invited to participate in the PiCSO-AMI-V Inferior STEMI study. After consent as per approved ethics committee requirements, baseline assessments will be performed. PCI of the culprit vessel should be performed per standard practices. After TIMI flow restoration, the subjects meeting all eligibility criteria will be enrolled into the study and randomized either to PiCSO Group or Control Group. If the subject is randomized to PiCSO Group, the coronary sinus (CS) will be cannulated through the femoral vein and the PiCSO Impulse Catheter will be placed in the CS. In the event the PiCSO Impulse Catheter cannot be placed in the CS within 30 minutes, the physician should proceed with the regular PCI and the PiCSO treatment will be considered a failure. Once PiCSO Impulse Catheter is placed into CS, PiCSO treatment is started followed by stenting. The physician shall target a PiCSO treatment of 45 minutes whereas the treatment should be continued during and post stent insertion. At the end of the PiCSO treatment, the PiCSO Impulse Console is stopped and the PiCSO Impulse Catheter is removed. The patient is seen for a FU visit at 12-36 hours, 30 days, 6 months and 1 year post index procedure. 12-36 hours and 6 months post index the patient will get a echocardiogram. At every FU visit safety data and health status will be documented. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06013813 -
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
|
N/A | |
| Terminated |
NCT04542889 -
Coronary Microcirculation Assessment After Primary Angioplasty in Myocardial Infarction
|
N/A | |
| Recruiting |
NCT04951856 -
Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
|
Phase 4 | |
| Terminated |
NCT04459299 -
CorPath GRX STEMI Study
|
||
| Recruiting |
NCT05557019 -
Semi Occlusion of the Coronary Sinus as an Adjunct to PCI in STEMI Patients, FIH Clinical Study
|
N/A | |
| Completed |
NCT03527940 -
Prognostic Markers of Patients With STEMI
|
||
| Not yet recruiting |
NCT03264859 -
NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction
|
N/A | |
| Not yet recruiting |
NCT03182855 -
Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
|
Phase 4 | |
| Not yet recruiting |
NCT03266289 -
Evaluation of Short Term Outcome of Different Bifurcation Stenting Techniques at Assuit University Cath. Lab
|
N/A | |
| Withdrawn |
NCT04566289 -
Observational Registry to Evaluate Real World Usage of PiCSO Impulse System in STEMI Patients as Part of Post-marketing Surveillance
|
||
| Completed |
NCT04289012 -
HELicobacter Pylori Screening in Patients With Acute Myocardial Infarction Pilot Study
|
N/A | |
| Not yet recruiting |
NCT04185077 -
Bivalirudin in Late PCI for Oatients With STEMI
|
Phase 4 | |
| Completed |
NCT03609346 -
Asian Registry of the BioFreedom Stent for STEMI Patients
|
||
| Recruiting |
NCT05107076 -
Effect of PPCI on Diastolic Function & Levels of Galactin-3 in Patients With STEMI
|
||
| Recruiting |
NCT02998853 -
Non Culprit Functional Evaluation With 3D Angio QFR in STEMI PCI Procedure
|
N/A | |
| Completed |
NCT03677180 -
National Cardiogenic Shock Initiative
|
||
| Completed |
NCT03507777 -
ILUMIEN IV: OPTIMAL PCI
|
N/A | |
| Recruiting |
NCT03863327 -
EKG Criteria and Identification of Acute Coronary Occlusion
|
||
| Completed |
NCT03070496 -
Multicenter Cohort of STEMI Patients
|
N/A | |
| Active, not recruiting |
NCT03874338 -
CLEAR SYNERGY Neutrophil Substudy
|